An alphaherpesvirus exploits antimicrobial β-Defensins to initiate respiratory tract infection.
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
How herpesviruses circumvent mucosal defenses to promote infection of new hosts through the respiratory tract remains unknown due to a lack of host-specific model systems. We used the alphaherpesvirus equine herpesvirus type 1 (EHV1) and equine respiratory tissues to decipher this key event in general alphaherpesvirus pathogenesis. In contrast to several respiratory viruses and bacteria, EHV1 resisted potent antimicrobial equine β-defensins (eBDs) eBD2 and eBD3 by the action of glycoprotein M. Instead, eBD2 and -3 facilitated EHV1 particle aggregation and infection of rabbit kidney (RK13) cells. In addition, virion binding to and subsequent infection of respiratory epithelial cells were increased upon preincubation of these cells with eBD1, -2, and -3. Infected cells synthesized eBD2 and -3, promoting further host cell invasion by EHV1. Finally, eBD1, -2, and -3 recruited leukocytes, which are well-known EHV1 dissemination and latency vessels. The exploitation of host innate defenses by herpesviruses during the early phase of host colonization indicates that highly specialized strategies have developed during host-pathogen coevolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was demonstrated that EHV-1 virions are resistant to the antimicrobial properties of eBD through the action of EHV-1 gM, which stabilizes the viral envelope and protects it from eBD permeabilization (Van Cleemput et al., 2020).”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as Van Cleemput et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using a chemotaxis assay, it was demonstrated that EHV-1 upregulates the expression of CXCL9, CXCL10, eBD2, and 3 in EREC and induces the recruitment of CD172a+ cells and T lymphocytes to the site of infection (Poelaert et al., 2019c; Van Cleemput et al., 2020).”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as Van Cleemput et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both studies indicated that primary replication of EHV-1 neurovirulent strains in the URT attracted significantly more CD172a+ cells and T lymphocytes to the infected epithelium than non-neurovirulent strains.”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as Van Cleemput et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, Van Cleemput and colleagues showed that EHV-1 exploits antimicrobial equine β-defensins (eBD) to initiate viral replication and spread within the URT.”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as Van Cleemput et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“Pretreatment of primary respiratory epithelial cells (EREC) with eBD increased EHV-1 virion binding and infection of these cells.”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as Van Cleemput et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsudaira, P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,950
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Schägger, H. (2006) · Nature Protocols · doi:10.1038/nprot.2006.4 · Cited by 2,507
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809 · cited 1×
“Human BD1 and -2 and mouse BD2 also induce a well-controlled chemotaxis of leukocytes (16, 17).”
BackgroundIsolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008557200 · Cited by 1,311
Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2
Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. J., et al. (2002) · Science · doi:10.1126/science.1075565 · Cited by 902
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., & Selsted, M. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114198 · Cited by 715
Mammalian defensins in immunity: more than just microbicidal
Yang, D., Biragyn, A., Kwak, L. W., & Oppenheim, J. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02246-9 · Cited by 696
Production of β-defensins by human airway epithelia
Singh, P. K., Jia, H. P., Wiles, K., Hesselberth, J., Liu, L., Conway, B.-A. D., Greenberg, E. P., Valore, E. V., Welsh, M. J., Ganz, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14961 · Cited by 579
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V, Zasloff, M., & Wilson, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2410 · Cited by 577
Cited by
Defensins: A Double-Edged Sword in Host Immunity
Xu, D., & Lu, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00764 · Cited by 242
Defensins: The natural peptide antibiotic
Gao, X., Ding, J., Liao, C., Xu, J., Liu, X., & Lu, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114008 · Cited by 160
Promising role of defensins peptides as therapeutics to combat against viral infection
Solanki, S. S., Singh, P., Kashyap, P., Sansi, M. S., & Ali, S. A. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104930 · Cited by 93
The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1
Laval, K., Poelaert, K. C. K., Van Cleemput, J., Zhao, J., Vandekerckhove, A. P., Gryspeerdt, A. C., Garré, B., van der Meulen, K., Baghi, H. B., Dubale, H. N., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.662686 · Cited by 54
Self-citationEquine Herpesvirus-1 Myeloencephalopathy
Pusterla, N., Hussey, G. S., & Goehring, L. S. (2022) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2022.05.006 · Cited by 37
Metadata
- Authors
- Van Cleemput, J., Poelaert, K. C. K., Laval, K., Vanderheijden, N., Dhaenens, M., Daled, S., Boyen, F., Pasmans, F., & Nauwynck, H. J.
- Affiliations
- Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
- Fox Chase Cancer Center (US)
- Princeton University (US)
- Ghent University (BE)
- Corresponding author
- Nauwynck, Hans J.
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2020-03-31
- Volume
- 94
- Issue
- 8
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC7108845
- OpenAlex
- W3003895548
- Cited by
- 13
- References
- 71
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 2
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (publishedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Funders
- Fonds Wetenschappelijk Onderzoek (11Y5415N)
- Agentschap voor Innovatie door Wetenschap en Technologie (141627)
- Bijzonder Onderzoeksfonds (01G01317)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- alphaherpesvirus, equine herpesvirus 1, host innate immunity, respiratory infections, glycoprotein M, host cell invasion, airway epithelial cells, leukocyte recruitment, viral latency, host-pathogen coevolution, equine respiratory disease
- MeSH terms
- Animals, Anti-Infective Agents, Cell Line, Epithelial Cells, Herpesvirus 1, Equid, Herpesviridae Infections, Horse Diseases, Horses, Rabbits, Respiratory Tract Infections, Viral Envelope Proteins, Alphaherpesvirinae, beta-Defensins, Host-Pathogen Interactions, Immune Evasion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An alphaherpesvirus exploits antimicrobial β-Defensins to initiate respiratory tract infection. https://app.cochat.ai/papers/10.1128/jvi.01676-19
- The paper
- Van Cleemput, J., Poelaert, K. C. K., Laval, K., Vanderheijden, N., Dhaenens, M., Daled, S., Boyen, F., Pasmans, F., & Nauwynck, H. J. (2020). An alphaherpesvirus exploits antimicrobial β-Defensins to initiate respiratory tract infection. Journal of Virology. https://doi.org/10.1128/jvi.01676-19
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.